Laurion Capital Management’s Epizyme, Inc EPZM Stock Holding History

Laurion Capital Management’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,885,100	Closed	-$4.24M	–	646
2022 Q2	$4.24M	Buy	+2,885,100	New	+$2.12M	0.07%	181
2017 Q4	–	Sell	-237,859	Closed	-$4.53M	–	1945
2017 Q3	$4.53M	Buy	+237,859	New	+$3.63M	0.02%	535
2014 Q2	–	Sell	-50,900	Closed	-$1.16M	–	362
2014 Q1	$1.16M	Buy	+50,900	New	+$1.54M	0.04%	169

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Laurion Capital Management's EPZM Position: Q3 2022 in Review

Laurion Capital Management sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 2,885,100 shares — an estimated $4.24M sold.

Laurion Capital Management first reported a position in EPZM in Q1 2014 and held it in 3 quarters. The position peaked at $4.53M in Q3 2017. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Laurion Capital Management reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Laurion Capital Management sold 2,885,100 Epizyme, Inc shares in Q3 2022, an estimated $4.24M.
Laurion Capital Management first reported a position in Epizyme, Inc in Q1 2014 and held it in 3 quarters.
Laurion Capital Management's Epizyme, Inc position peaked at $4.53M in Q3 2017.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Laurion Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.